Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3250208
Title:
7-BENZYL-4-(4-(TRIFLUOROMETHYL)BENZYL)-1,2,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(4H)-ONE, SES SELS ET LEUR UTILISATION EN THERAPIE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
167442375
WO application number:
US2016015817
Type:
European patent granted for BE
Status:
Open
Publication number:
3250208
WO publication number:
WO2016123571
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
29/01/2016
Grant date:
30/09/2020
EP publication date:
06/12/2017
WO publication date:
04/08/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
30/09/2020
EP B1 publication date:
30/09/2020
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
29/01/2036
Applicant
Name:
Oncoceutics, Inc.
Legal Form:
From:
30/09/2020
Address:
3675 Market Street
Suite 200, Philadelphia, PA 19104, United States (US)
To:
Agent
Name:
NOVAGRAAF BREVETS
Legal Form:
From:
26/11/2020
Address:
Bâtiment O2
2 rue Sarah Bernhardt
CS90017, 92665, Asnières-sur-Seine Cedex, France (FR)
To:
Inventor
1
Name:
STOGNIEW, Martin
Legal Form:
Address:
Florida 34202, United States (US)
2
Name:
ALLEN, Joshua E.
Legal Form:
Address:
New Haven, Connecticut 06511, United States (US)
3
Name:
POTTORF, Richard S.
Legal Form:
Address:
Indianapolis, Indiana 46526, United States (US)
4
Name:
NALLAGANCHU, Bhaskara Rao
Legal Form:
Address:
Hillsborough, New Jersey 08852, United States (US)
5
Name:
OLSON, Gary L.
Legal Form:
Address:
Mountainside, New Jersey 07092, United States (US)
6
Name:
SUN, Yanjun
Legal Form:
Address:
Kendall Park, New Jersey 08824, United States (US)